Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Jun 12, 2019 01:52 PM IST | Source: PTI

Alembic Pharma to raise up to Rs 300 cr via NCDs

The company, which did not specify the reasons for rasing funds, said it will issue NCDs in one or more tranches.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Alembic Pharmaceuticals on Wednesday said its board has approved raising of up to Rs 300 crore through issuance of non-convertible debentures (NCDs) on a private placement basis.

The company, which did not specify the reasons for rasing funds, said it will issue NCDs in one or more tranches.

"The board of directors of Alembic Pharmaceuticals Ltd....has approved the issue of unsecured listed rated redeemable non-convertible debentures (NCDs) of up to Rs 300 crore on a private placement basis," the company said in a regulatory filing.

Close
Shares of Alembic Pharmaceuticals were trading 0.03 percent higher at Rs 502.20 apiece on the BSE.

Subscribe to Moneycontrol Pro and gain access to curated markets data, exclusive trading recommendations, independent equity analysis, actionable investment ideas, nuanced takes on macro, corporate and policy actions, practical insights from market gurus and much more.
First Published on Jun 12, 2019 01:49 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant